Rigel Pharmaceuticals RIGL Earnings Call Transcripts

NASDAQ RIGL
$43.91 +1.86 (+4.42%)
At close: Nov 10, 2026 · 4:00 PM EST
6 earnings calls on file for Rigel Pharmaceuticals, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Rigel Pharmaceuticals Q2 2026 Earnings Call

Aug 4, 2026 6,631 words · 29 min read
  • Raul RodriguezPresident and Chief Executive Officer
  • David SantosChief Commercial Officer
  • Dean SchornoChief Financial Officer
  • Alison HannahChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Rigel Pharmaceuticals Earnings Call Transcripts

Calls6
LatestAug 4, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2020

Fiscal 2019

All 6 Rigel Pharmaceuticals transcripts Register to get access to Rigel Pharmaceuticals’s earnings call transcripts.